Medicine
Efavirenz, Emtricitabine and Tenofovir disoproxil 600 mg/200 mg/300 mg tablet
Efavirenz, Emtricitabine and Tenofovir disoproxil 600 mg/200 mg/300 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). • Keep container tightly closed. •…
Key facts
- Active ingredient (INN)
- Efavirenz, Emtricitabine and Tenofovir disoproxil
- Brand
- Sold under the generic name
- Strength
- 600 mg/200 mg/300 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 90 tablets and 5 more
- Manufacturers
- Laurus LabsIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaCiplaIndiaMacleods PharmaceuticalsIndiaBryant Ranch PrepackTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). • Keep container tightly closed. • Dispense only in original container.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AR06 Efavirenz, Emtricitabine and Tenofovir disoproxil
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 October 2020
- Identifiers
- RxCUI 643066DailyMed set ID 5f261872-d705-4549-a43d-2ad6b0164dc3, fc9c2149-8d40-401b-af13-5ae7f953950a, 1b71df95-b1ce-4e40-908a-67fb336457f4 +4NDC 31722-736, 0093-5234, 65862-497 +4Application ANDA203053, ANDA091215, ANDA203041 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 65862-497-30 | Aurobindo PharmaIndia | 30 March 2021 |
| 30 tablet, film coated in 1 bottle | 31722-736-30 | Camber PharmaceuticalsIndia | 24 January 2022 |
| 30 tablet, film coated in 1 bottle | 69097-210-02 | CiplaIndia | 30 March 2021 |
| 30 tablet, film coated in 1 bottle | 42385-915-30 | Laurus LabsIndia | 22 December 2021 |
| 90 tablet, film coated in 1 bottle | 42385-915-90 | Laurus LabsIndia | 22 December 2021 |
| 30 tablet, film coated in 1 bottle | 33342-138-07 | Macleods PharmaceuticalsIndia | 13 September 2021 |
| 30 tablet, film coated in 1 bottle | 0093-5234-56 | Teva Pharmaceuticals | 1 October 2020 |
| 30 tablet, film coated in 1 bottle | 72162-2565-3 | Bryant Ranch Prepack | 4 November 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Efavirenz, Emtricitabine and Tenofovir disoproxil is a fixed-dose combination of a human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor, a hepatitis B virus nucleoside analog reverse transcriptase inhibitor and a human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor. MedsAcross supplies Efavirenz, Emtricitabine and Tenofovir disoproxil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Efavirenz, Emtricitabine and Tenofovir disoproxilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Efavirenz, emtricitabine and tenofovir disoproxil fumarate prescribing information (Laurus Labs) · U.S. National Library of Medicine, DailyMed
- Efavirenz/Emtricitabine/Tenofovir disoproxil Krka: European public assessment report (EPAR) · European Medicines Agency
- Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan: European public assessment report (EPAR) · European Medicines Agency
Need Efavirenz, Emtricitabine and Tenofovir disoproxil 600 mg/200 mg/300 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.